ArticlePloS one2022

Analytical and clinical validation of a custom 15-gene next-generation sequencing panel for the evaluation of circulating tumor DNA mutations in patients with advanced non-small-cell lung cancer.

Yock Ping Chow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.